Technology News and Research

RSS

Misonix commences direct to hospital sales of its SonaStar Ultrasonic Surgical Aspirator in the US

Misonix, Inc., (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today announced the second expansion of its direct sales channel for the United States, which was first disclosed in June 2008.

2 Sep 2009

Merge Healthcare acquires Confirma

With the completion of its acquisition of Confirma, Inc. today, Merge Healthcare Incorporated (NASDAQ: MRGE) has enhanced its medical imaging capabilities to become a market leader in MRI computer-aided detection (CAD) applications. The combined business now has the capability to widen the global adoption of CAD technology through Merge’s international distribution network, as well as provide broader interoperability of this important tool within the health IT enterprise.

2 Sep 2009

Study reveals that antibiotics used to treat a variety of bacterial infections could cause double vision

Highlights of September's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy), include a 2009 review by the Academy of the safety and efficacy of a widely used corneal transplant procedure and a warning about an unusual but serious reaction to systemic fluoroquinolones, a class of antibiotics used to treat a variety of bacterial infections.

2 Sep 2009

Nanodiamonds: A novel gene delivery technology

Gene therapy holds promise in the treatment of a myriad of diseases, including cancer, heart disease and diabetes, among many others. However, developing a scalable system for delivering genes to cells both efficiently and safely has been challenging.

2 Sep 2009

GE Healthcare to develop wireless medical monitoring systems for patient care

In what would represent an important step forward in revolutionizing the way patients are monitored in the future, GE announced an initiative aimed to develop wireless medical monitoring systems, or body sensor networks (BSN), which would replace the traditional tangle of bedside cables used to capture a patient’s vital signs. GE’s vision for the systems would enable wireless monitoring from anywhere in the hospital—or even remotely from home.

2 Sep 2009

Vitro Diagnostics develops technology and products for cell-based cancer therapy

Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced advances in its adult stem cell products and technology with application to cell-based therapy of cancer. With the passing of Senator Edward Kennedy from brain cancer, we are reminded of such aggressive cancers without effective treatment.

2 Sep 2009

Children's Hospital Oakland converts to Masimo Rainbow SET Pulse CO-Oximetry technology

Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Children's Hospital & Research Center Oakland has completed its system-wide conversions to Masimo Rainbow SET Pulse CO-Oximetry technology.

2 Sep 2009

Visioneer document scanner streamlines patient care delivery systems

There is constant pressure in the healthcare industry to streamline patient care delivery systems that will function effectively under the real world constraints faced by public and private hospitals. Whether it is an admissions process, patient records or a doctor’s office environment, Visioneer scanners make short and easy work out of converting paper into digital documents.

2 Sep 2009

Teaching hospitals are no better than non-teaching hospitals in providing routine medical care

Teaching hospitals are well-known for having cutting edge technology and specialty services for highly complex illnesses. They are household names you consider when a loved one is facing a difficult health issue.

2 Sep 2009

New research on post-traumatic stress disorder to be presented at MHRF

New research on post-traumatic stress disorder (PTSD) is being presented this week at the Military Health Research Forum (MHRF), a scientific conference hosted by the Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). Depending on the conflict in which they served, 10 to 30 percent of soldiers who have spent time in war zones experience the debilitating and life-altering symptoms of post-traumatic stress disorder (PTSD).

2 Sep 2009

TeleForum to discuss H1N1 precautions on campus

In response to the Centers for Disease Control and Prevention's expectation of increased cases of H1N1 flu as students return to school this fall, Colorado-based Broadnet is offering a unique package of its virtual town hall service, TeleForum, to colleges and universities in an effort to aid communication with parents, communities and students.

2 Sep 2009

Results of fiscal year 2009 announced by Biomerica

Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, today reported net sales for the fiscal year 2009 were $4,934,771 versus net sales of $4,926,505 in fiscal 2008.

1 Sep 2009

Telemonitoring systems enable early detection of silent, asymptomatic arrhythmias in heart

An increasing number of heart failure patients are treated with a number of complex devices, i.e. cardiac resynchronization therapy (CRT). Recently completed and ongoing clinical trials such as MADIT-CRT and EchoCRT provide evidence of a growing number of CRT patients, in need of individualised treatment.

1 Sep 2009

Rising Medical Solutions provides five solutions to change America's healthcare system

Controlling healthcare costs seems like a complex issue but one expert points to an age-old economic model to save our nation billions of dollars.

1 Sep 2009

H1N1 flu vaccine forms processing service launched by Quality Associates

Quality Associates, Inc. (QAI) www.qualityassociatesinc.com, an established provider of services and solutions for large-scale document management, imaging, and archiving, announced the launch of its H1N1 Flu Vaccine Forms Processing Service, a comprehensive approach to help states, cities, counties, and providers in the private sector successfully and accurately capture and record essential demographic and health data from medical consent forms – a critical step in the administration of the H1N1 vaccine to millions nationwide beginning this fall.

1 Sep 2009

Endosense raises USD 36 million in Series B financing

Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received USD 36 million in Series B financing. Edmond de Rothschild Investment Partners (EdRIP) led the round, with additional participation from Neomed, Gimv, VI Partners (VI), Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.

1 Sep 2009

Medical device report provides key data, information and analysis on diagnostic imaging market

Global Markets Direct’s medical device report: “The Future of the Diagnostic Imaging Market to 2015” report provides key data, information and analysis on the global diagnostic imaging market. The report provides market landscape, competitive landscape and market trends information on six market categories including computed tomography systems, mammography equipment, MRI systems, nuclear imaging equipment, ultrasound systems and x-ray systems.

1 Sep 2009

BioClinica offers streamlined electronic transport solutions with the acquisition of CardioNow

BioClinica, Inc., (NASDAQ: BIOC), a global provider of clinical trial services, today announced that it has acquired the CardioNow unit of Agfa HealthCare.

From Clario 1 Sep 2009

Ceragenix Pharmaceuticals updates license agreement covering antimicrobial technology use

Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the “Company”), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive evaluation and option to license agreement (the "Agreement”) with a global, multi-billion dollar healthcare company covering the use of the Company's CeraShield antimicrobial technology for a specific medical device associated with a high incidence of hospital acquired infections.

1 Sep 2009

TransPharma's Phase 2A trial of ViaDerm-hPTH(1-34) for treating severe osteoporosis is successful

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of the Phase 2A trial of ViaDerm-hPTH(1-34) which is being developed for the treatment of severe osteoporosis.

1 Sep 2009

Technology News and Research

Misonix commences direct to hospital sales of its SonaStar Ultrasonic Surgical Aspirator in the US

Merge Healthcare acquires Confirma

Study reveals that antibiotics used to treat a variety of bacterial infections could cause double vision

Nanodiamonds: A novel gene delivery technology

GE Healthcare to develop wireless medical monitoring systems for patient care

Vitro Diagnostics develops technology and products for cell-based cancer therapy

Children's Hospital Oakland converts to Masimo Rainbow SET Pulse CO-Oximetry technology

Visioneer document scanner streamlines patient care delivery systems

Teaching hospitals are no better than non-teaching hospitals in providing routine medical care

New research on post-traumatic stress disorder to be presented at MHRF

TeleForum to discuss H1N1 precautions on campus

Results of fiscal year 2009 announced by Biomerica

Telemonitoring systems enable early detection of silent, asymptomatic arrhythmias in heart

Rising Medical Solutions provides five solutions to change America's healthcare system

H1N1 flu vaccine forms processing service launched by Quality Associates

Endosense raises USD 36 million in Series B financing

Medical device report provides key data, information and analysis on diagnostic imaging market

BioClinica offers streamlined electronic transport solutions with the acquisition of CardioNow

Ceragenix Pharmaceuticals updates license agreement covering antimicrobial technology use

TransPharma's Phase 2A trial of ViaDerm-hPTH(1-34) for treating severe osteoporosis is successful

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News